Cannabis Europa 2026: Paris & London

Where Cannabis Policy Meets Business Opportunity

2 Events
1750+ Attendees
120+ Speakers
50 Exhibitors

Where Cannabis policy meets business opportunity

Cannabis Europa provides premium conference and exhibition experiences for Europe’s legal cannabis industry — connecting people and ideas that invoke changes in policy, commerce and capital flow.

 

Our events unite policymakers, investors, and business leaders to navigate the continent’s rapidly-evolving market.

the voices LEADING the CONVERSATION

Our speakers are global thought-leaders driving change in policy, investment, and commerce. Engage with their perspectives, challenge your thinking, and leave with actionable insights to accelerate commercial growth.  

CEO, ANANDA PHARMA PLC
PRESIDENT, UNION OF COFFEESHOP RETAILERS (NETHERLANDS)
MANAGING DIRECTOR (STRATEGIC COMMUNICATIONS), FTI CONSULTING
FORMER PROFESSIONAL TENNIS PLAYER, WIMBLEDON CHAMPION
CHAIRMAN OF THE BOARD, BEDROCAN
NATIONAL DRUG COORDINATOR, OFFICE OF THE GOVERNMENT OF THE CZECH REPUBLIC
MEMBER OF UK PARLIAMENT, LABOUR PARTY
TV PERSONALITY, RAPPER & FOUNDER, BDL GENETICS
MEP FOR THE NETHERLANDS, EUROPEAN PARLIAMENT
PROFESSOR OF PSYCHOLOGY, COLUMBIA UNIVERSITY
CEO, CO-FOUNDER & MANAGING DIRECTOR, CANSATIVA GROUP
CO-FOUNDER, THINK BIG & FRANK WHITE
MANAGING PARTNER, CASA VERDE
FOUNDER, LAST PRISONER PROJECT
HEAD OF RESEARCH, DRUG SCIENCE
FORMER MEMBER OF PARLIAMENT OF THE UNITED KINGDOM
MEMBER OF UK PARLIAMENT, LABOUR PARTY
HEAD OF NEUROPSYCHOPHARMACOLOGY, IMPERIAL COLLEGE LONDON
PROFESSOR, MAPLE TREE MEDICAL CANNABIS CONSULTANCY
EXECUTIVE CHAIRMAN, CURALEAF

Defining What Comes Next for Cannabis in Europe

Immerse yourself in bold ideas, powerful networking, and the conversations driving the evolution of Europe’s cannabis industry. Leave with knowledge and connections you need to lead.

Take a look back at some of the standout sessions that have shaped Cannabis Europa in recent years — the debates, insights, and ideas that continue to influence the industry today.

Join us in Paris & London in 2026: Secure Your Seat

Book your tickets now for Paris & London 2026. Connect with the policymakers, investors, and innovators defining what comes next for cannabis in Europe.

Super Early Bird Pass
Standard
£334.49

LONDON – 26-27 MAY 2026

Full access to all conference talks, networking areas and exhibition floor.

*Prices rise on 2 Dec 2025

VIP Pass
Premium
£756.59

LONDON – 26-27 MAY 2026

Includes all Standard benefits plus premium upgrades: VIP lounge access, priority seating, concierge assistance, lunch on both days.

*Prices rise on 2 Dec 2025

VIP Pass + BofC Awards
Premium
£840.00

LONDON – 26-27 MAY 2026

Includes all VIP ticket benefits plus entry to the Business of Cannabis Awards party on the evening of 26 May, 2026.

*Prices Rise on 2 Dec 2025

Super Early Bird Pass
Standard
€214.39

PARIS – 19 FEBRUARY 2026

Full access to all conference talks and networking areas.

*Prices rise on 5 December 2025

Super Early Bird Pass
Standard
€214.39

PARIS – 19 FEBRUARY 2026

Full access to all conference talks and networking areas.

*Prices rise on 5 December 2025

VIP Pass + BofC Awards
Premium
£840.00

LONDON – 26-27 MAY 2026

Includes all VIP ticket benefits plus entry to the Business of Cannabis Awards party on the evening of 26 May, 2026.

*Prices Rise on 2 Dec 2025

VIP Pass
Premium
£756.59

LONDON – 26-27 MAY 2026

Includes all Standard benefits plus premium upgrades: VIP lounge access, priority seating, concierge assistance, lunch on both days.

*Prices rise on 2 Dec 2025

Super Early Bird Pass
Standard
£334.49

LONDON – 26-27 MAY 2026

Full access to all conference talks, networking areas and exhibition floor.

*Prices rise on 2 Dec 2025

A History of Leading Europe’s Cannabis Conversation

Since 2018, Cannabis Europa has united industry leaders, innovators, and policymakers to define the direction and drive momentum across Europe’s cannabis markets.

past event 1past event 1
past event 4past event 4
past event 3past event 3
past event 2past event 2
past event 5past event 5

what THE CANNABIS EUROPA COMMUNITY SAYS

We were truly honoured to sponsor the VIP Lounge and be part of an event that continues to set the standard for meaningful dialogue and progress in the medical cannabis industry. The professionalism and welcoming atmosphere you created made it easy for everyone to connect, exchange ideas, and explore new opportunities. We had the pleasure of engaging with inspiring individuals from across the industry, and we left feeling excited and optimistic about the future.
Adriano Fernandez
Business Development Manager
I was blown away by the quality of contacts that I had the opportunity to network with at the event, and I’m sure that next year we’ll be participating once again.
Agustin Mimbacas
Export Promotion Specialist
Uruguay XXI
The show was absolutely amazing! The venue allowed for more engaging business conversations and time to address all questions. Our team greatly appreciated the opportunity to be a part of this event, and look forward to seeing everyone next year.
Chubby Gorilla
United States
Working with Prohibition Partners for Cannabis Europa has been an absolute pleasure. Their dedication, exceptional professionalism, and collaborative spirit have made a meaningful difference, and we sincerely value their support.
Vladimir Kofcegarski
CEO
PHCANN
We had a great event! Thank you to the whole Cannabis Europa team for all your hard work. Beth, Rachel – thank you! We were absolutely blown away by the interest at our stand. The team is looking forward to following up with all of our new connections next week.
Dunbar Pharma
Ireland

Latest News, Views & Research

France Medical Cannabis Market 2026: Regulations, Access & Reimbursement Guide

On 31 March 2026, France will shut the door on its five-year medical cannabis pilot. On 1 April, the country enters a permanent, pharmaceutical-style regime — one that will determine access, pricing, supply, and prescriber rights for the next decade. For an industry long locked out of France, this moment is arguably more consequential than […]

Medical Cannabis Sales in Germany Expected to Reach €420 Million in 2024

Following the adoption of the CanG and the associated MedCanG Act, the German medical cannabis market is witnessing significant growth, with German medical cannabis sales expected to reach €420 million in 2024, rising to over €1 billion by 2028. Published today in The German Cannabis Report by Prohibition Partners, this projection is fueled by several factors, including […]

Cannabis Europa 2023 – Day 2

The second day of Cannabis Europa London 2023 began with a look back at the early beginnings of the cannabis business, following an engaging first day of panels centered on the sector’s future. Raphael Mechoulam, the ‘Father of Cannabis Research,’ who passed away in March at the age of 92, was honoured before the opening […]

Cannabis Europa 2023 – Day 1

Cannabis Europa, the largest cannabis conference in Europe, had its ninth edition this week, returning to the Barbican Centre for the first time since it began in 2018. It attracted over a thousand business executives, important EU policymakers, and patient advocates.  On Tuesday morning, Prohibition Partners CEO Stephen Murphy gave a warm welcome to guests […]

Stay informed on cannabis policy and market trends

Subscribe to receive the latest updates on cannabis regulation, investment, and innovation in Europe.

Thank you for your interest!

Our team appreciates your engagement, and one of our managers will reach out to you shortly.